|
|
Focus on Innovation:
LifeNet Health Introduces New Product: Oracell™ Decellularized Dermis for Dental and Maxillofacial Applications available November 1, 2010
 Oracell™ is an acellular dermal matrix intended to be used in conjunction with guided tissue and bone regeneration, and oral soft tissue correction. MATRACELL™, a patented and validated technology by LifeNet Health, renders Oracell allograft dermis acellular without compromising biomechanical or biological properties.
This decellularized matrix retains the native constituents needed for successful use.
• Cells and > 97% DNA are removed yielding low immunogenic potential
• Intact acellular framework retains native growth factors, collagen and elastin*
• Ambient temperature storage allows for excellent handling and minimal prep time (less than 60 sec)
• Pull-out strength and load to failure are comparable to existing allograft products*
• Sterile quality (10-6 SAL Sterility Assurance Level) means increased safety for your patients
This patented and validated process renders allografts acellular, while retaining the desired physiological properties for its intended surgical application.
*Data on file at LifeNet Health, Virginia Beach, VA.
|
